Metabolic Syndrome
Conditions
Keywords
metabolic syndrome, insufficient exercise
Brief summary
The main purpose of this study is to validate the effect of an individualized exercise prescription developed based on cardiopulmonary exercise testing (CPET) in subjects with metabolic syndrome. This study aims to assess the improvement in cardiovascular metabolic risk associated with the personalized exercise regimen,known as individualized HIIT.
Interventions
BEHAVIORALHIIT
Three times a week, 10 sets each session, for 24 weeks of high-intensity interval training.
Sponsors
Beijing Chao Yang Hospital
Guangdong Provincial People's Hospital
Peking University Shenzhen Hospital
The First Affiliated Hospital of Shanxi Medical University
Qingdao Municipal Hospital
Peking University Third Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Age between 30 and 65, for both males and females; 2. Inadequate exercise: Sedentary lifestyle: Sitting for more than 6 hours daily over the past 6 months; Insufficient physical activity evaluated by the International Physical Activity Questionnaire (IPAQ), with an average weekly duration of moderate-intensity physical activity less than 150 minutes or high-intensity physical activity less than 75 minutes; 3. Meeting the criteria for metabolic syndrome according to the 2009 AHA/IDF definition: Must have three or more of the following: Abdominal obesity(Waist circumference ≥90 cm for males, ≥80 cm for females); Elevated fasting blood glucose: ≥5.6 mmol/L; Elevated blood pressure: Systolic blood pressure ≥130 mm Hg, or diastolic blood pressure ≥85 mm Hg; Elevated fasting triglycerides (TG): ≥1.7 mmol/L (150 mg/dl); Reduced fasting high-density lipoprotein cholesterol (HDL-C): \<1.0 mmol/L for males, \<1.3 mmol/L for females. Additionally, must meet the following conditions: TG \<500 mg/dl (5.6 mmol/L); fasting blood glucose \<7 mmol/L; baseline blood pressure \<140/90 mm Hg; 4. Willingness to improve health status through reasonable exercise.
Exclusion criteria
1. Contraindications to CPET (Cardiopulmonary Exercise Testing); 2. Positive results in CPET exercise electrocardiogram; 3. The patient has elevated LDL-C levels and has been indicated for statin therapy. 4. Currently undergoing treatment with antihypertensive, antidiabetic, lipid-lowering, or antiarrhythmic medications; 5. The doctor evaluates dietary supplements or over-the-counter medications that may affect the results (such as fish oil products, red yeast rice extract, over-the-counter weight loss drugs, meal replacements, probiotics, berberine, etc.) 6. Mental disorders; 7. Conditions related to exercise impairment, or occurrence of lower limb exercise-related injuries in the past 6 months; 8. Women who are pregnant, breastfeeding, or planning to become pregnant in the near future; 9. Other situations deemed unsuitable for participation in this study by the researchers; 10. Refusal to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in composite cardiovascular disease risk score (z-score) | through study completion, an average of 2 year | The primary outcome is the change from baseline in the composite cardiovascular disease risk score (z-score) calculated using resting blood pressure, high-density lipoprotein cholesterol, fasting glucose, waist circumference and triglyceride. Each risk factor will be individually standardized and expressed as sex-specific z-score by using the formula = (value - mean)/standard deviation for each participant. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Biochemical and metabolic indicators | through study completion, an average of 2 year | Biochemical indicators including GLU(mmol/L),CHO(mmol/L),TG(mmol/L),LDL-C(mmol/L),HDL-C(mmol/L) etc. |
| CPET (Cardiopulmonary Exercise Testing) related indicators | through study completion, an average of 2 year | Peak oxygen uptake（ml/min） |
| calf circumference, waist circumference, and hip circumference | through study completion, an average of 2 year | Indicators in terms of length include: calf circumference, waist circumference, and hip circumference |
| Oral Glucose Tolerance Test (OGTT) Related Indicators | through study completion, an average of 2 year | Fasting Blood Glucose and Insulin, 30-minute Postprandial Blood Glucose and Insulin, 120-minute Postprandial Blood Glucose and Insulin. |
Countries
China
Contacts
Primary ContactJun Gao, PhD
Outcome results
None listed